Biotech Winners And Losers Out Of ASH
A slew of biotech companies studying blood disease treatments presented data this past weekend at the annual American Society of Hematology (ASH) meeting – and,…
Zenect Wealth
High Growth And Reasonable Risk: 2 Biotech Stocks To Consider
“In such a volatile market, it is quite difficult to find reasonably safe and high-growth biotech stocks,” acknowledges the author of today’s article. Of course,…
2 Biotech ETFs To Monitor For Potential Breakouts – And Possible Trading Plays For Both
With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s…
An Options Strategy For This COVID Vaccine Play With More Room To Run
When it comes to COVID-19 vaccine manufacturers, the author of today’s article notes “While it’s no surprise that investors have already bought into these companies,…
New Biotech Stocks To Watch – And More!
Companies involved in spectroscopy, bioelectronic medicine and telemedicine make up the three new biotech stocks to watch highlighted in today’s article, which also highlights new…
“Out Of Favor Healthcare Stocks Poised For Growth”: An Investing Theme For A Return To Normal
With the COVID-19 pandemic resulting in reduced doctor visits and delayed surgeries and procedures, many healthcare stocks have suffered this year. But as things begin…
How Will The Election Results Affect Tech, Growth, Biotech And Healthcare – And Who Will Outperform?
While President Trump still refuses to concede and control of the Senate is still technically to be determined, a Biden presidency come January 20th appears…
An ETF To Play The Biotech Sector Well Into 2021
For bullish biotech investors looking for a way to play the sector well into 2021, today’s article highlights an ETF to consider for that purpose,…
Biotech Stocks Of Every Kind For Investors Of Every Kind In 2021
From traditional “Big Pharma” stocks that have adopted (or are adopting) a greater focus on biotech to large “pure-play” biotech companies to “emerging” biotech stocks…
23 Stocks And ETFs That Stand To Benefit From A Biden Administration’s Changes (Or A Split Congress’ Lack Of Change)
From the country’s strategy for tackling COVID-19 to U.S.-China tensions to government regulations, some key changes can be expected under the coming Biden administration. At…